KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Cash from Investing Activities (2016 - 2025)

Boston Scientific's Cash from Investing Activities history spans 17 years, with the latest figure at -$512.0 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 86.18% year-over-year to -$512.0 million; the TTM value through Dec 2025 reached -$2.6 billion, up 53.58%, while the annual FY2025 figure was -$2.6 billion, 53.58% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$512.0 million at Boston Scientific, down from -$502.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $71.0 million in Q1 2021 and bottomed at -$3.7 billion in Q4 2024.
  • The 5-year median for Cash from Investing Activities is -$500.0 million (2025), against an average of -$763.6 million.
  • The largest annual shift saw Cash from Investing Activities surged 193.42% in 2021 before it plummeted 2796.55% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$461.0 million in 2021, then soared by 60.3% to -$183.0 million in 2022, then plummeted by 475.41% to -$1.1 billion in 2023, then plummeted by 251.76% to -$3.7 billion in 2024, then skyrocketed by 86.18% to -$512.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Cash from Investing Activities are -$512.0 million (Q4 2025), -$502.0 million (Q3 2025), and -$1.1 billion (Q2 2025).